Open access

PREVALENCE OF HBV, HIV, AND HIV-HBV CO-INFECTIONS AMONG HEALTHCARE WORKERS IN IBADAN, NIGERIA
Oluyinka Opaleye, Olusola Akanbi, Michael Binuyo

BMJ Global Health Feb 2017, 2 (Suppl 2) A45; DOI: 10.1136/bmjgh-2016-000260.119
CHILD PROTECTION AND DEVELOPMENT: ADDRESSING THE PROBLEMS OF HIV/AIDS ORPHANS – A CASE STUDY IN BAHIR DAR TOWN, ETHIOPIA
Ayele Tamene

BMJ Global Health Feb 2017, 2 (Suppl 2) A45-A46; DOI: 10.1136/bmjgh-2016-000260.121
UNDERSTANDING PATIENT DECISIONS TO TRANSFER OR DISENGAGE FROM HIV CARE AND TREATMENT IN ZAMBIA
Stephanie Topp, Chanda Mwamba, Laura Beres, Nancy Padian, Izukanji Sikazwe, Elvin Geng, Charles Holmes

BMJ Global Health Feb 2017, 2 (Suppl 2) A46; DOI: 10.1136/bmjgh-2016-000260.122
MEETING FIELD-BASED CHALLENGES: INNOVATIVE APPROACHES TO COLLECTING DRY BLOOD SPOT SAMPLES IN THE COMMUNITY
Kombatende Sikombe, Cardinal Hantuba, Nancy Czaicki, Elvin Geng, Charles Holmes, Kalo Musukuma, Sandra Simbeza, Paul Somwe, Izukanji Sikazwe

BMJ Global Health Feb 2017, 2 (Suppl 2) A46; DOI: 10.1136/bmjgh-2016-000260.123
CHANGES IN VAGINAL PRACTICES AFTER CONTRACEPTIVE VAGINAL RING USE AMONG WOMEN IN KIGALI, RWANDA
Michele Umulisa, Jennifer Ilo, Evelyne Kestelyn, Mireille Uwineza, Stephen Agaba, Therese Delvaux, Janneke Wijgert

BMJ Global Health Feb 2017, 2 (Suppl 2) A47; DOI: 10.1136/bmjgh-2016-000260.124
HIV INFECTION AND CARDIOVASCULAR RISK PROFILE IN A RURAL SOUTH AFRICAN POPULATION: THE NDLOVU COHORT STUDY
Alinda Vos, Walter Devillé, Roos Barth, Kerstin Klipstein-Grobusch, Hugo Tempelman, François Venter, Roel Coutinho, Diederick Grobbee

BMJ Global Health Feb 2017, 2 (Suppl 2) A10; DOI: 10.1136/bmjgh-2016-000260.22
PHYLOGENETIC AND DEMOGRAPHIC CHARACTERISATION OF HIV-1 TRANSMISSION NETWORKS IN A GENERAL POPULATION COHORT IN UGANDA
Deogratius Ssemwanga, Frederick Lyagoba, Brian Magambo, Anne Kapaata, Joseph Kirangwa, Maria Nannyonjo, Faridah Nassolo, Rebecca Nsubuga, Gonzalo Yebra, Andrew Brown, Pontiano Kaleebu

BMJ Global Health Feb 2017, 2 (Suppl 2) A10; DOI: 10.1136/bmjgh-2016-000260.23
NEW POSSIBILITIES FOR THE DEVELOPMENT OF A COMBINED VACCINE AGAINST ETEC AND SHIGELLA
Richard Walker

BMJ Global Health Feb 2017, 2 (Suppl 2) A11-A12; DOI: 10.1136/bmjgh-2016-000260.26
PREVALENCE AND RISK FACTORS FOR EFAVIRENZ-BASED ANTIRETROVIRAL TREATMENT-ASSOCIATED SEVERE VITAMIN D DEFICIENCY: A PROSPECTIVE COHORT STUDY
Hanna Nylén, Abiy Habtewold, Eyasu Makonnen, Getnet Yimer, Jürgen Burhenne, Ulf Diczfalusy, Eleni Aklillu

BMJ Global Health Feb 2017, 2 (Suppl 2) A11; DOI: 10.1136/bmjgh-2016-000260.24
THE BURDEN AND FUTURE SCOPE FOR IMPORTANT VIRAL ENTERIC PATHOGENS IN AFRICA
Duncan Steele

BMJ Global Health Feb 2017, 2 (Suppl 2) A11; DOI: 10.1136/bmjgh-2016-000260.25

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages